Compare ECOR & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | TPCS |
|---|---|---|
| Founded | 2005 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 40.9M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | TPCS |
|---|---|---|
| Price | $4.90 | $4.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $25.50 | N/A |
| AVG Volume (30 Days) | 33.0K | ★ 49.1K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,835,000.00 | ★ $33,564,000.00 |
| Revenue This Year | $28.61 | N/A |
| Revenue Next Year | $41.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.90 | 1.15 |
| 52 Week Low | $4.16 | $2.05 |
| 52 Week High | $19.49 | $6.25 |
| Indicator | ECOR | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 50.58 |
| Support Level | $4.75 | $4.05 |
| Resistance Level | $5.09 | $4.68 |
| Average True Range (ATR) | 0.21 | 0.20 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 24.39 | 72.06 |
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.